PT  - JOURNAL ARTICLE
AU  - Burton, Joshua
AU  - Rounge, Trine B.
AU  - Haugen, Trine B.
AU  - Wojewodzic, Marcin W.
TI  - Pre-Diagnostic Circulating RNAs Networks Identify Testicular Germ Cell Tumour Susceptibility Genes
AID  - 10.1101/2022.12.16.22283563
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2022.12.16.22283563
4099  - http://medrxiv.org/content/early/2023/01/26/2022.12.16.22283563.short
4100  - http://medrxiv.org/content/early/2023/01/26/2022.12.16.22283563.full
AB  - Testicular germ cell tumour (TGCT) is a malignancy with known inherited risk factors, affecting young men. We have previously identified several hundred circulating RNAs that were differentially expressed in pre-diagnostic serum samples from TGCT cases when compared to healthy controls. In this study we performed network preservation analyses of pre-diagnostic serum mRNA and miRNA. Hub genes, enriched functional pathways, and regulatory feature prediction were identified for all TGCT, seminoma, and non-seminoma cases separately, compared to controls. We identified UBCA1, RCC1, FMR1, OSA3, and UBE2W as hub genes associated with TGCT. The genes OSA3 and UBE2W have previously been associated with testicular dysgenesis syndrome (TDS) disorders. Previously described TGCT susceptibility genes TEX14, NARS2, and G3BP2 were identified as hub genes in both seminoma and non-seminoma networks. Furthermore, network module analysis showed prediction of transcription factors for oestrogen-related receptors. The overlap between network hub genes and TGCT susceptibility genes indicates a role in the progression from germ cell neoplasia in situ (GCNIS) to TGCT that should be further investigated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by internal funding of OsloMet Oslo Metropolitan University and Cancer Registry of Norway.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies involving human participants were reviewed and approved by the Norwegian Regional Committee for Medical and Health Research Ethics (REC no: 2016/1290). The patients/participants provide their written informed consent to participate in this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated for this article are not readily available because of the principles and conditions set out in articles 6 (1) (e) and 9 (2) (j) of the General Data Protection Regulation (GDPR). National legal basis as per the Regulations on population-based health surveys and ethical approval from the Norwegian Regional Committee for Medical and Health Research Ethics (REC) are also required. Requests to access the datasets should be directed to the corresponding authors.The datasets generated for this article are not readily available because of the principles and conditions set out in articles 6 (1) (e) and 9 (2) (j) of the General Data Protection Regulation (GDPR). National legal basis as per the Regulations on population-based health surveys and ethical approval from the Norwegian Regional Committee for Medical and Health Research Ethics (REC) are also required. Requests to access the datasets should be directed to the corresponding authors.